STRUCTURE/FUNCTION STUDIES OF ANTIGEN/ANTIBODY REACTIONS
STRUCTURE/FUNCTION STUDIES OF ANTIGEN/ANTIBODY REACTIONS
批准号:
2191960
负责人:
Roy A Mariuzza
金额:
$17.74万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-19 至 1997-08-31
关键词:
X ray crystallography antibody specificity antigen antibody reaction antiidiotype antibody chemical binding chemical stability conformation crystallization enzyme linked immunosorbent assay hydrogen bond hydropathy immune complex immunogenetics immunoglobulin genes immunoglobulin structure intermolecular interaction lysozyme microcalorimetry molecular cloning monoclonal antibody mutant protein engineering protein structure function site directed mutagenesis thermodynamics
中文摘要
抗体是一种功能强大、用途广泛的结合分子,它可以免疫
系统用来消除外来抗原,因此构成了一个
阐明大分子原理的极佳模型
承认。了解抗体功能的分子基础是
对于深入了解免疫反应和
开发抗体作为治疗工具(例如,通过
啮齿动物抗体的“人性化”)。
我们建议探索抗原-抗体识别的分子基础。
通过详细的定点突变体的结构和功能的研究
抗鸡蛋清溶菌酶(HEL)单抗D1.3,具有
是我们实验室广泛的结构研究的主题。为
这些实验,蛋白质工程的,细菌表达的FvD1.3
将使用的碎片作为自由的三维结构
FV和FV-HEL复合体的FV分辨率为1.8埃;
这应该允许更严格地解释站点定向
比目前对任何其他抗原都可能进行的诱变实验-
抗体系统。FV突变体旨在研究FV的特定方面
蛋白质-蛋白质(抗原-抗体)识别的问题将是
以对抗原的亲和力和反应性为特征的。
选定的FvD1.3突变体与HEL络合将被结晶并进行X射线检查
将进行结晶学分析以准确确定
特定氨基酸取代在结构水平上的影响。在……里面
此外,将使用滴定量热法来确定熵和
以关联为目的的结合反应的热变
这些热力学参数与X射线模型相吻合。
研究亲和力是如何对特定的蛋白质抗原成熟的
决定因素是由免疫系统实现的,随机突变
抗体基因与新近开发的方法相结合
丝状噬菌体表面的抗体展示将是
用于模拟这一过程并分离D1.3的变体,改进后的
对抗原的亲和力。的三维结构
与HEL络合的相应Fv片段将在
为了了解观察到的增长的结构性基础
亲和力。
据设想,这项基础工作将产生一个Fv突变体库
已知的结构和亲和力,将作为建模的基础
抗原-抗体反应的结构和热力学参数。
这将大大促进旨在从头开始的努力。
抗体亲和力和结合部位构象的预测,以及
从而促进了用于医疗和医疗的抗体分子的工程
化学应用。
英文摘要
Antibodies are powerful and versatile binding molecules that the immune
system employs to eliminate foreign antigens and as such constitute an
excellent model for elucidating the principles governing macromolecular
recognition. A knowledge of the molecular basis of antibody function is
also essential for an in-depth understanding of immune responses and for
the development of antibodies as therapeutic tools (e.g. through the
"humanization" of rodent antibodies).
We propose to explore the molecular basis of antigen-antibody recognition
through detailed structure-function studies of site-directed mutants of
the anti-hen egg-white lysozyme (HEL) monoclonal antibody D1.3, which has
been the subject of extensive structural studies in our laboratory. For
these experiments, the protein-engineered, bacterially-expressed FvDl.3
fragment will be used since the three-dimensional structures of the free
Fv and that of the Fv-HEL complex are known to 1.8 Angstrom resolution;
this should allow a more rigorous interpretation of site-directed
mutagenesis experiments than is currently possible for any other antigen-
antibody system. Fv mutants designed to investigate particular aspects of
the problem of protein-protein (antigen-antibody) recognition will be
characterized in terms of affinity and reactivity towards the antigen.
Selected FvD1.3 mutants complexed with HEL will be crystallized and X-ray
crystallographic analysis will be carried out to precisely ascertain the
effects of particular amino acid substitutions at the structural level. In
addition, titration calorimetry will be used to determine the entropy and
enthalpy changes of the binding reactions with the aim of correlating
these thermodynamic parameters with the X-ray models.
To investigate how affinity maturation towards a defined protein antigenic
determinant is achieved by the immune system, random mutagenesis of
antibody genes in combination with recently developed methods for the
display of antibodies on the surface of filamentous bacteriophage will be
used to mimic this process and to isolate variants of D1.3 with improved
affinity for antigen. The three-dimensional structures of the
corresponding Fv fragments complexed with HEL will then be determined in
order to understand the structural basis for the observed increases in
affinity.
It is envisaged that this basic work will generate a library of Fv mutants
of known structure and affinity which will serve as a basis for modelling
the structural and thermodynamic parameters of antigen-antibody reactions.
This should significantly contribute to efforts aimed at ab initio
prediction of antibody affinity and combining site conformation, and
thereby facilitate the engineering of antibody molecules for medical and
chemical applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Basis for T Cell Recognition of SARS-CoV-2
-
批准号:10592711
-
项目类别:
-
资助金额:$23.27万
-
财政年份:2023
-
负责人:Roy A Mariuzza
-
依托单位:
Structure, Function and Mechanistic Analysis of LAG3
-
批准号:10542350
-
项目类别:
-
资助金额:$71.2万
-
财政年份:2019
-
负责人:Roy A Mariuzza
-
依托单位:
Structure, Function and Mechanistic Analysis of LAG3
-
批准号:10317043
-
项目类别:
-
资助金额:$71.2万
-
财政年份:2019
-
负责人:Roy A Mariuzza
-
依托单位:
Structure, Function and Mechanistic Analysis of LAG3
-
批准号:10078854
-
项目类别:
-
资助金额:$71.2万
-
财政年份:2019
-
负责人:Roy A Mariuzza
-
依托单位:
Structure and Activation of a Multiprotein Signaling Complex
-
批准号:10238118
-
项目类别:
-
资助金额:$69.2万
-
财政年份:2017
-
负责人:Roy A Mariuzza
-
依托单位:
Structure and Activation of a Multiprotein Signaling Complex
-
批准号:9752433
-
项目类别:
-
资助金额:$70.18万
-
财政年份:2017
-
负责人:Roy A Mariuzza
-
依托单位:
Structure and Activation of a Multiprotein Signaling Complex
-
批准号:9448073
-
项目类别:
-
资助金额:$71.1万
-
财政年份:2017
-
负责人:Roy A Mariuzza
-
依托单位:
Structural Analysis of the TCR-CD3 Complex and TCR Signaling
-
批准号:9251684
-
项目类别:
-
资助金额:$70.04万
-
财政年份:2016
-
负责人:Roy A Mariuzza
-
依托单位:
Structural Analysis of the TCR-CD3 Receptor Complex
-
批准号:8512173
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2013
-
负责人:Roy A Mariuzza
-
依托单位:
Structural Analysis of the TCR-CD3 Receptor Complex
-
批准号:8605510
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2013
-
负责人:Roy A Mariuzza
-
依托单位:
Solution structure and dynamics of TCR in free and peptide-MHC-bound states
-
批准号:8301177
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2012
-
负责人:Roy A Mariuzza
-
依托单位:
Solution structure and dynamics of TCR in free and peptide-MHC-bound states
-
批准号:8416301
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2012
-
负责人:Roy A Mariuzza
-
依托单位:
CRYSTAL STRUCTURES OF TCR AND MHC AND CD4 COMPLEX
-
批准号:8363340
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2011
-
负责人:Roy A Mariuzza
-
依托单位:
Recombinant Antibodies from the Sea Lamprey
-
批准号:7707212
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2009
-
负责人:Roy A Mariuzza
-
依托单位:
STRUCT BAS FOR PEPTIDOGLYCAN RECOGNITION BY HUMAN PEPTIDOGLYCAN RECOGNITION
-
批准号:7955594
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2009
-
负责人:Roy A Mariuzza
-
依托单位:
Recombinant Antibodies from the Sea Lamprey
-
批准号:7898573
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2009
-
负责人:Roy A Mariuzza
-
依托单位:
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
-
批准号:7474448
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2008
-
负责人:Roy A Mariuzza
-
依托单位:
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
-
批准号:7880834
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2008
-
负责人:Roy A Mariuzza
-
依托单位:
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
-
批准号:8099588
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2008
-
负责人:Roy A Mariuzza
-
依托单位:
COMPLEX OF PHOSPHOLIPASE C GAMMA1, GADS AND AN SLP-76 MOTIF
-
批准号:7726245
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2008
-
负责人:Roy A Mariuzza
-
依托单位:
海外基金